Cargando…

1084 Persistence of Meningococcal Antibodies and Response to a Booster Dose after a Two-dose Vaccination Series with Investigational MenABCWY Vaccine Formulations in Adolescents

Detalles Bibliográficos
Autores principales:	Saez-Llorens, Xavier, Vaca, Diana Catalina Aguilera, Abarca, Katia, Maho, Emmanuelle, Han, Linda, Smolenov, Igor, Dull, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	IDWeek 2014 Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781662/ http://dx.doi.org/10.1093/ofid/ofu052.792

Ejemplares similares

1083 Comparative Evaluation of Two Different Investigational Meningococcal ABCWY Vaccine Formulations in Adolescents and Young Adults
por: Block, Stan L., et al.
Publicado: (2014)

1085 Persistence of Meningococcal Bactericidal Antibodies and Booster Response at 60-Months of Age in Children Who Received Infant Or Toddler Doses of MenACWY-CRM Conjugate Vaccine
por: Klein, Nicola P., et al.
Publicado: (2014)

Four-year antibody persistence and response to a booster dose of a pentavalent MenABCWY vaccine administered to healthy adolescents and young adults
por: Sáez-Llorens, Xavier, et al.
Publicado: (2018)

1146. Cost-effectiveness of the Pentavalent Meningococcal Vaccine (MenABCWY): A steady-state cohort modelling approach
por: Schley, Katharina, et al.
Publicado: (2023)

1638. Development of a Model to Estimate Persistence of hSBA Titers Over Time Following a Primary Series and Booster Dose of the Pentavalent Meningococcal MenABCWY Vaccine
por: Cai, Bing, et al.
Publicado: (2023)

1080 Antibody Persistence 5 Years After Vaccination at 2 to 10 Years of Age With Quadrivalent MenACWY-CRM Conjugate Vaccine, And Responses To a Booster Vaccination
por: Block, Stanley L., et al.
Publicado: (2014)

530 Disease Modulation in Older Adults Vaccinated with High-Dose Versus Standard-Dose Influenza Vaccine
por: Talbot, H. Keipp, et al.
Publicado: (2014)

1059 Expanded immunogenicity of high-dose inactivated influenza vaccine compared to standard-dose inactivated influenza vaccine in older adults
por: Diazgranados, Carlos, et al.
Publicado: (2014)

1055 Antibody Response to Intradermal and High Dose Influenza Vaccine in 2012-13 Among Adults Who Did and Did Not Respond to Standard Dose Vaccine in 2011-12
por: Sundaram, Maria, et al.
Publicado: (2014)

6. Pentavalent Meningococcal (MenABCWY) Vaccine is Safe and Well Tolerated With Immunogenicity Noninferior to Coadministered MenB-FHbp and MenACWY-CRM in a Phase 2 Study of Healthy Adolescents and Young Adults
por: Peterson, James, et al.
Publicado: (2020)

1078 Risk Factors Associated with Developing Fever Following First Dose Measles-Containing Vaccines
por: Klein, Nicola P., et al.
Publicado: (2014)

1087 Immunogenicity and Safety of 3-Dose Primary Vaccination with Combined DTPa-HBV-IPV/Hib Vaccine in Canadian Aboriginal and non-Aboriginal Infants
por: Scheifele, David W., et al.
Publicado: (2014)

Immunogenicity and Safety of Investigational MenABCWY Vaccine and of 4CMenB and MenACWY Vaccines Administered Concomitantly or Alone: a Phase 2 Randomized Study of Adolescents and Young Adults
por: Beran, Jiří, et al.
Publicado: (2021)

1110 Identification of Formulations and Vaccine Schedules of a Trivalent Group B Streptococcus Vaccine for Further Development in Non-pregnant and Pregnant Women
por: Leroux-Roels, Geert, et al.
Publicado: (2014)

1335 Transfer and Persistence of Antibodies in Infants Following Maternal Immunization with an Investigational Trivalent Group B Streptococcus Vaccine
por: Halperin, Scott A, et al.
Publicado: (2014)

1339 Measles and Mumps Antibody Response in Young Adults after a Third Dose of Measles-Mumps-Rubella Vaccine
por: Fiebelkorn, Amy Parker, et al.
Publicado: (2014)

651 Epidemiology of Serogroup B Meningococcal Outbreaks and Interim Guidelines for the Use of an Unlicensed Serogroup B Vaccine Under a CDC-Sponsored IND for the Control of Outbreaks in Organizational Settings
por: Meyer, Sarah, et al.
Publicado: (2014)

1089 Safety and Immunogenicity of DTaP-IPV (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliovirus Vaccine) Compared to DAPTACEL(®) (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed) + IPOL(®) (Poliovirus Vaccine Inactivated) as the 5th Dose in Children 4 to 6 Years of Age
por: Smith, Michael, et al.
Publicado: (2014)

393 Vancomycin Dosing in Obese Patients
por: Alquwaizani, Mohammed, et al.
Publicado: (2014)

599 Rapid rises in antibody titers observed following single dose administration of a novel 4-antigen Staphylococcus aureus vaccine (SA4Ag) to healthy adults
por: Frenck, Robert W., et al.
Publicado: (2014)

752 Assessment of Aminoglycoside Dosing at a Large Academic Medical Center
por: Ghamrawi, Riane, et al.
Publicado: (2014)

1742 Impact of Material and Social Seprivation on Serogroup B Invasive Meningococcal Disease (IMD-B) Incidence and Outcomes in the Province of Quebec, Canada
por: Tapiero, Bruce, et al.
Publicado: (2014)

1067 Multi-Attribute Ranking Tool for Vaccines: Strategic Priority Setting to Support Vaccine Development
por: Madhavan, Guruprasad, et al.
Publicado: (2014)

392 Vancomycin Dosing and Concentrations at a Large University-Affiliated County Hospital
por: Youn, Gilmer, et al.
Publicado: (2014)

1050 Evaluation of syncope and related events following vaccination with quadrivalent human papillomavirus vaccine (2006-2013)
por: Lievano, Fabio, et al.
Publicado: (2014)

203 Optimization of Posaconazole (PCZ) Dosing with Multi-disciplinary Therapeutic Monitoring (TDM) Protocol
por: Pettit, Natasha, et al.
Publicado: (2014)

405 Risk of gentamicin vestibulotoxicity with different dosing regimens: a retrospective cohort study
por: Leis, Jerome, et al.
Publicado: (2014)

652 An Investigation of the Recommendation Styles and Same-Day Vaccination Rates for Pediatricians Discussing HPV Vaccine with Adolescent Patients & Their Caregivers
por: Clark, Liana, et al.
Publicado: (2014)

485 Colistin Nephrotoxicity in Critically Ill Patients after Implementation of a New Dosing Strategy
por: Özel, Ayşe Serra, et al.
Publicado: (2014)

204 Voriconazole Restriction in Addition to Therapeutic Drug Monitoring (TDM) Protocol Results in Optimized Dosing
por: Pettit, Natasha, et al.
Publicado: (2014)

1575 A 28-day high-dose safety and pharmacokinetics study of raltegravir in healthy subjects
por: Krishna, Rajesh, et al.
Publicado: (2014)

827 The efficacy of single dose peramivir in acute uncomplicated influenza: an integrated subject-level meta-analysis
por: Whitley, Richard, et al.
Publicado: (2014)

490 High Dose Tigecycline for the Treatment of Multi-Drug Resistant Gram Negative Urinary Tract Infections
por: Sam, Sharon, et al.
Publicado: (2014)

192 Vancomycin Dosing in Obese and Morbidly Obese Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Pneumonia
por: Morrill, Haley, et al.
Publicado: (2014)

1096 Impact of Universal Pneumococal Vaccination in Children in Argentina
por: López, Eduardo L., et al.
Publicado: (2014)

1077 Adverse events following measles, mumps, and rubella (MMR) vaccine in adults reported to the Vaccine Adverse Event Reporting System, 2003-2013
por: Sukumaran, Lakshmi, et al.
Publicado: (2014)

Immunogenicity and safety of different schedules of the meningococcal ABCWY vaccine, with assessment of long-term antibody persistence and booster responses – results from two phase 2b randomized trials in adolescents
por: Vesikari, Timo, et al.
Publicado: (2021)

662 Missed opportunities for influenza vaccination among inpatients with influenza
por: Rao, Suchitra, et al.
Publicado: (2014)

1097 Cost-Effectiveness of Pneumococcal Vaccines for Adults in the United States
por: Yang, H. Keri, et al.
Publicado: (2014)

1088 Provider and patient attitudes regarding adult pertussis vaccination
por: Suryadevara, Manika, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6r8gi7g18oq3ddmv3b8vbbhj7b